Category: Baxter International
Here's a look at some of the top legal news stories for medical device companies this week: Baxter drops FloSeal case against J&J; Feds: We got $119m in fraud penalties from medtech companies last year; Insurer, DJO Global settle pain pump suit
, Boston Scientific
, CareFusion Corp.
, Dept. of Health & Human Services (HHS)
, Dept. of Justice (DOJ)
, DJO Global
, Ethicon Inc.
, Ironshore Specialty Insurance
, Johnson & Johnson
, Omni Surgical/Spine360
, Smith & Nephew
, Abbott Laboratories
, Genzyme Corp.
Here's a look at some of the top regulatory stories for medical device companies this week: FDA expands indication for On-X Life's heart valve; More CT scanner problems for Philips Healthcare; Augmenix wins FDA nod for SpaceOar prostate treatment; Biotronik launches Pantera Pro balloon catheter in Europe; Baxter wins CE Mark for home dialysis device
Baxter International drops its patent suit against Johnson & Johnson over the technology behind Baxter's FloSeal hemostasis device.
Baxter International wins CE Mark approval in the European Union for its HomeChoice Claria device for home peritoneal dialysis treatments.
The lobbying spend in Washington hit a 16-year high of nearly $33 million in 2014, as the industry continued its fight to repeal Obamacare's medical device tax.
The medical device industry's lobbying spend hit its highest point since 1998 last year, nearing $33 million, as the industry stepped up its campaign to repeal the medical device tax enacted as part of Obamacare.
Baxter bests analysts' forecasts for its 4th-quarter results but issues a cautious outlook for the 1st quarter.
China closes out an anti-dumoing probe into foreign dialysis kit makers including Fresenius, Nikkiso and Nipro.